Personal information

Other IDs

Loop profile: 721164

Keywords

Bovine immunology, Vaccines, Animal Health, Infection diseases, Microbiology, Viral diseases of livestock, Clinical trials, Public Health, Zoonotic diseases

Countries

Chile

Biography

I am a veterinarian and a PhD student in Biological Sciences, with a great passion for cattle.

Activities

Collapse all

Education and qualifications (4)

Pontificia Universidad Católica de Chile: Santiago, CL

2022-03-07 to present | PhD candidate in Biological Sciences, mention Molecular Genetic and Microbiology
Qualification
Source: Self-asserted source
Daniela B. Rivera

Pontificia Universidad Católica de Chile: Santiago, CL

2022-03-07 to 2023-06-30 | Master in Biological Sciences
Education
Source: Self-asserted source
Daniela B. Rivera

Universidad de Chile: Santiago, Región Metropolitana, CL

2016-02-26 to 2016-02-28 | Course: Calf and Replacement Heifer Breeding
Education
Source: Self-asserted source
Daniela B. Rivera

Universidad Santo Tomás: Santiago, CL

2012 to 2016 | Veterinarian
Qualification
Source: Self-asserted source
Daniela B. Rivera

Professional activities (3)

Pontificia Universidad Catolica de Chile: Santiago, Metropolitana, CL

2018-07-01 to 2022-03-01 | Veterinarian (Laboratorio de Inmunología Molecular Biomédica)
Invited position
Source: Self-asserted source
Daniela B. Rivera

Universidad de las Américas, Chile: Santiago, Chile, CL

2018-07-01 to 2018-09-01 | Professor Public Health
Invited position
Source: Self-asserted source
Daniela B. Rivera

Universidad Santo Tomás: Santiago, CL

2018-03-01 to 2018-07-01 | Professor in Animal Reproduction
Invited position
Source: Self-asserted source
Daniela B. Rivera

Funding (3)

ANID - Doctorado Nacional

2022-03 to 2026-03 | Award
Agencia Nacional de Investigación y Desarrollo (Santiago, CL)
Source: Self-asserted source
Daniela B. Rivera

Reconocimiento por destacados méritos académicos

2017-12 to present | Award
Universidad Santo Tomás (Santiago, CL)
Source: Self-asserted source
Daniela B. Rivera

Reconocimiento por haber obtenido el mejor rendimiento académico a nivel nacional 2017

2017-10 to 2017-10 | Award
Colegio Médico Veterinario de Chile (COLMEVET) (Santiago, Metropolitana, CL)
URL: https://colmevet.cl
Source: Self-asserted source
Daniela B. Rivera

Works (12)

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents

Frontiers in Immunology
2024-05-15 | Journal article
DOI: 10.3389/fimmu.2024.1372193
Part of ISSN: 1664-3224
Contributors: Daniela Rivera-Pérez; Constanza Méndez; Benjamín Diethelm-Varela; Felipe Melo-González; Yaneisi Vázquez; Xing Meng; Qianqian Xin; Rodrigo A. Fasce; Jorge Fernández; Judith Mora et al.
Source: Self-asserted source
Daniela B. Rivera

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults

eBioMedicine
2023-05 | Journal article
DOI: 10.1016/j.ebiom.2023.104563
Part of ISSN: 2352-3964
Contributors: Constanza Méndez; Hernan Penaloza; Bárbara M. Schultz; Alejandro Piña-Iturbe; Mariana Ríos; Daniela Moreno-Tapia; Patricia Pereira-Sánchez; Diane Leighton; Claudia Orellana; Consuelo Covarrubias et al.
Source: Self-asserted source
Daniela B. Rivera

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children

mBio
2022-12-20 | Journal article
DOI: 10.1128/mbio.01311-22
Part of ISSN: 2150-7511
Contributors: Jorge Soto ; Felipe Melo-Gonzalez; Cristián Gutierrez-Vera; Bárbara M. Schultz; Roslye V. Berríos-Rojas; Daniela Rivera-Pérez; Alejandro Piña-Iturbe; Guillermo Hoppe-Elsholz; Luisa Fernanda Duarte Peñaloza; Yaneisi Vázquez et al.
Source: Self-asserted source
Daniela B. Rivera

From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection

Expert Opinion on Drug Discovery
2022-11-02 | Journal article
DOI: 10.1080/17460441.2022.2123468
Part of ISSN: 1746-0441
Part of ISSN: 1746-045X
Contributors: Jorge Soto ; Nicolás Marcelo Salvador Gálvez Arriagada; D.B Rivera; F.E Díaz; C.A Riedel; Susan M. Bueno; Alexis Kalergis
Source: Self-asserted source
Daniela B. Rivera

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

eLife
2022-10-13 | Journal article
DOI: 10.7554/elife.81477
Part of ISSN: 2050-084X
Contributors: Nicolás Marcelo Salvador Gálvez Arriagada; Gaspar Pacheco; Bárbara M. Schultz; Felipe Melo-Gonzalez; Jorge Soto ; Luisa Fernanda Duarte Peñaloza; Liliana A González; Daniela Rivera-Pérez; Mariana Ríos; Roslye V Berrios et al.
Source: Self-asserted source
Daniela B. Rivera

Female offspring gestated in hypothyroxinemia and infected with human Metapneumovirus (hMPV) suffer a more severe infection and have a higher number of activated CD8+ T lymphocytes

Frontiers in Immunology
2022-09-08 | Journal article
DOI: 10.3389/fimmu.2022.966917
Part of ISSN: 1664-3224
Contributors: Samanta C. Funes; Mariana Ríos; Ayleen Fernández-Fierro; Daniela Rivera-Pérez; Jorge A. Soto; José R. Valbuena; María J. Altamirano-Lagos; Felipe Gómez-Santander; Evelyn L. Jara; Pablo Zoroquiain et al.
Source: Self-asserted source
Daniela B. Rivera

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern

mBio
2022-08-30 | Journal article
DOI: 10.1128/mbio.01423-22
Part of ISSN: 2150-7511
Contributors: Bárbara M. Schultz; Felipe Melo-González; Luisa F. Duarte; Nicolás Marcelo Salvador Gálvez Arriagada; Gaspar Pacheco; Jorge Soto ; Roslye V. Berríos-Rojas; Liliana A. González; Daniela Moreno-Tapia; Daniela Rivera-Pérez et al.
Source: Self-asserted source
Daniela B. Rivera

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.

Frontiers in immunology
2021-11-09 | Journal article
DOI: 10.3389/fimmu.2021.747830
PMID: 34858404
PMC: PMC8630786
Source: Self-asserted source
Daniela B. Rivera

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.

Frontiers in immunology
2021-09-29 | Journal article
DOI: 10.3389/fimmu.2021.742914
PMID: 34659237
PMC: PMC8511644
Source: Self-asserted source
Daniela B. Rivera

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Frontiers in immunology
2021-04-26 | Journal article
DOI: 10.3389/fimmu.2021.664212
PMID: 33981309
PMC: PMC8108697
Source: Self-asserted source
Daniela B. Rivera

Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice

Immunology
2019-12 | Journal article
DOI: 10.1111/imm.13119
Part of ISSN: 0019-2805
Part of ISSN: 1365-2567
Contributors: Samanta C. Funes; Mariana Ríos; Felipe Gómez‐Santander; Ayleen Fernández‐Fierro; María J. Altamirano‐Lagos; Daniela Rivera‐Perez; Raul Pulgar‐Sepúlveda; Evelyn L. Jara; Diego Rebolledo‐Zelada; Alejandra Villarroel et al.
Source: Self-asserted source
Daniela B. Rivera

Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus

Frontiers in Microbiology
2019-05-03 | Journal article
DOI: 10.3389/fmicb.2019.00873
Part of ISSN: 1664-302X
Contributors: María José Altamirano-Lagos; Fabián E. Díaz; Miguel Andrés Mansilla; Daniela Rivera-Pérez; Daniel Soto; Jodi L. McGill; Abel E. Vasquez; Alexis M. Kalergis
Source: Self-asserted source
Daniela B. Rivera
How many people are using ORCID?